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2) Ion chamber-based measurements reported local dose differences 
(calculated vs measured) between 0.2 and 4.8% 
3) Dynalog file-based analysis revealed DVH differences below 1% for 
all the oulined structures when the reconstructed plans were 
compared to the original plans. 
Conclusions: Our results show that IMRS plans consisting of fixed 
beams and a single isocenter can be delivered with high dosimetric 
accuracy in order to treat multiple brain metastases. This approach 
probably allows to reduce the treatment time respect to the use of a 
isocenter for each lesion.  
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Purpose/Objective: The COSTAR trial (CRUK-08/004) has been open 
since 2008 and recruited 104 patients to date from 20 UK centres. 
Prior to recruitment each centre completes a benchmark planning and 
outlining exercise in accordance with national RTTQA IMRT 
credentialing processes. The first three cases recruited are then 
submitted for case review prior to treatment. In order to ensure 
efficiency and reduce workload for clinical trials personnel, we 
reviewed this process to determine if further streamlining could be 
incorporated for future trials. 
Materials and Methods: The COSTAR trial is a multicentre randomised 
study of cochlear sparing with IMRT versus conventional Radiotherapy 
in patients with parotid tumours and is designed to determine the 
potential of IMRT to reduce the incidence of sensori neural hearing 
loss. Case reviews have been retrospectively assessed and categorised 
as to those cases that required minor or major changes to CTV 
contours, adjustments to organ at risk (OAR) contours,dose 
prescription errors and unacceptable plans. Minor changes to the CTV 
were defined as those not likely to affect primary or secondary 
endpoints of the trial primarily due to the fact that the changes would 
not impact on the resultant plan that is produced. Major changes were 
those likely to affect the primary or secondary endpoints and would 
alter the resultant plan. Two dose prescriptions for the parotid bed 
were specified in the trial protocol of 60Gy or 65Gy in 30 fractions 
dependent on the presence of macroscopic residual disease at 
surgery.  
Results: Six of the 43 cases submitted for review required replanning: 
4 due to incorrect dose prescription, 1 plan was sub-optimal and the 
final case required major modifications to the CTV and a sub-optimal 
plan had been submitted. After review of several cases it became 
apparent that there were more concerns with the contours than the 
plans so centres were encouraged to submit contours prior to 
planning. Thirteen cases had outlines submitted for review prior to 
planning; 3 of these required major modifications to the CTV which 
prevented the need for repeat planning by a centre. Minor 
modifications to the CTV were requested for 9 cases. Thirteen of the 
43 case reviews submitted required outlining alterations to OARs 
which would not have impacted on the plan produced but would have 
resulted in incorrect doses being reported for these organs. 
Conclusions: The case review process has been shown to be a useful 
tool in clinical trials as 9 cases submitted required intervention before 
treatment to comply with the protocol. Centres submitting outlines 
for review prior to planning streamlines the process by highlighting 
any contouring errors and preventing replans. It is unlikely that 100% 
protocol compliance will be achieved for future trials but case reviews 
can still reveal issues not highlighted during the benchmark process.  
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Purpose/Objective: Vero4DRT(MHI-TM2000) has a capability of non-
coplanar irradiation by performing RING rotation around a vertical axis 
as well as GANTRY rotation around an axis perpendicular to the gantry 
rotation plane. The purpose of this study was to propose a patient-
specific collision detection simulator among a gantry, a couch, and a 
patient for the Vero4DRT system 
Materials and Methods: 3D surface models comprised of triangular 
polygons were created based on the Vero4DRT's design for the 
treatment unit and the couch, respectively. For the treatment unit 
model, RING rotation around a vertical axis was simulated within an 
angle range of ±60 degrees while GANTRY rotation around an axis 
perpendicular to the gantry rotation plane was simulated within an 
angle range of ±185 degrees. In addition, maximum angular speed was 
set to 7 deg/sec for GANTRY rotation and 3 deg/sec for RING rotation, 
respectively. For the couch model, the translation from the isocenter 
was simulated within a range of ±150 mm in LR, -918 through 682 mm 
in SI, and -488 through 50 mm in AP directions, respectively. 
Furthermore, the motion velocity was set to 5-15 mm/sec in LR, 10-50 
mm/sec in SI, 5-30 mm/sec in AP directions, respectively.  
Subsequently, 3D point data of body surface of a patient were 
acquired using a 3D scanner (Artec MHT, Artec, Luxembourg) with a 
resolution of 0.5 mm and a frame rate of 15 fps. From the acquired 3D 
point data, a 3D surface model of the patient was created using 
Marching Cube method. Furthermore, a decimation technique was 
applied to reduce the polygon meshes. Next, each 3D surface model 
was arranged in the virtual treatment room. The collision detection 
among the above models was performed using a physics engine 
middleware SDK (PhysX, Nvidia, USA) to be computed on the graphics 
board. The above simulator was implemented using C++. We have 
performed preliminary simulation of collision detection among the 
treatment unit, the couch, and the patient under several geometric 
conditions. 
Results: The proposed simulator was implemented on a PC with an 
Intel Core2 Quad CPU Q9400 2.66 GHz, 4 GB RAM, and a VN220GT-
MD1G/D3 VGA board. The rotational function of the treatment unit 
was simulated with an accuracy of 0.1 degrees for given parameters 
and that the collision between them was detected (Fig. 1a). 
Furthermore, the collision maps of the gantry and the ring angles at a 
couch position were created for simple patient models of different 
body size (Fig. 1b). The calculation time was approximately three 
minutes. 
 
 
Conclusions: We have proposed a patient-specific collision detection 
simulator among the gantry, the couch, and the patient for the 
Vero4DRT system using the geometric design and the physics engine 
middleware SDK. The result suggests that it may be useful for collision 
avoidance in treatment planning of dynamic irradiation.  
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Purpose/Objective: We are currently investigating the feasibility of 
adding total marrow irradiation with a conventional myeloablative 
regimen of Fludarabine and IV Busalfan prior to allogeneic stem cell 
transplant. This reports our initial clinical experience utilizing this 
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novel approach regarding patient setup uncertainty and accuracy in 
treatment delivery.  
Materials and Methods: Twelve patients with advanced hematological 
malignancies were treated according to our institutional phase I 
clinical trial, which is designed to determine the feasibility and the 
tolerability of dose escalation using intensity-modulated total marrow 
irradiation (IMTMI) in combination with Fludarabine/ IV Busulfan in 
patients with high risk of relapse undergoing allogeneic hematopoietic 
stem cell transplantation. Patients were immobilized using customized 
whole body alpha cradle and light cast for the head. All bones 
excluding the mandible, maxilla,arms and lower extremities were 
contoured on CT scans and a 3 mm margin was added to obtain the 
planning target volume (PTV). This method provided greater than 5 
mm margin around the bone marrow, which is the clinical target 
volume (CTV). Organs at risk (OAR) including the brain, lenses, oral 
cavity, lungs,heart, liver, kidney, rectum, bladder, and small bowel 
were contoured by the attending physicians. Three separate 
treatment plans, one for H&N, one for chest, and one for the pelvic 
region were generated in Eclipse. Plans were optimized for a 
minimum 95%PTV coverage by the prescription dose. Plan QA was 
performed with film and ion chamber array analysis. Precise 
positioning and alignment of all three isocenters were confirmed prior 
to each treatment with MV port films. Setup errors for each patient 
were retrospectively analyzed by co-registering port films and 
reconstructed radiographs using Varian's offline review 
software.Dosimetric consequences of the determined setup errors 
were evaluated by shifting the isocenters accordingly. We used 
Brainlab Exactract kV imaging to treat one patient. A comparison of 
targeting and dose accuracy was also performed between the MV and 
kV setup. 
Results: The setup errors were all less than 5 mm, in vertical (3.2±1 
mm), lateral (2.3±1 mm), and longitudinal (3.3±1 mm) directions. 
When a 5 mm setup error in all directions was simulated, the percent 
bone marrow that received the 95% of the prescription dose (V95) 
reduced from 99.4%to 97.2% while the median lung dose was reduced 
from 62% to 58%. We have observed that the kV imaging improved the 
setup error to be less than 1mm while reducing the setup time more 
than by half to be 8 minutes per field. 
Conclusions: Linac-based IM-TMI technique is clinically feasible 
affording significant normal tissue sparing in a combined chemo-RT 
regimen. We concluded that a 3 mm bone to PTV expansion was 
adequate to accurately target bone marrow in IM-TMI treatments and 
the kV imaging improved delivery accuracy while reducing the setup 
time considerably. 
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Purpose/Objective: To quantify the geometrical and dosimetrical 
uncertainty associated with the treatment chain of linac-based 
frameless intracranial stereotactic radiotherapy (SBT) combining end-
to-end phantom tests and clinical data. The obtained information is 
used to assess the adequateness of the employed margin for GTV-PTV 
expansion and establish action levels for the evaluation of pre-
treatment dose verification measurements. 
Materials and Methods: Data from 55 consecutive patients treated for 
brain metastases between 2010 and July 2012 at the Catharina 
Hospital in Eindhoven, the Netherlands were used to quantify the 
uncertainty associated with: (1) the registration between the planning 
computed tomography (CT) and magnetic resonance (MR) scans, (2) 
interobserver variation in target volume delineation, (3) pre-
treatment verification measurements with the Delta4 phantom, (4) CT 
and cone beam CT (CBCT) registration and (5) intra-fraction motion. 
To assess the overall geometrical and dosimetrical accuracy of the 
clinical treatment chain, an end-to-end-test was performed that 
mimicked the clinical procedure, using a phantom with a film 
embedded (6). This test was repeated on both linacs used for 
intracranial stereotactic radiotherapy. 
Results:  
(1) Differences in translations and rotations with respect to the 
average MR-CT registration matrix were on average 1 mm and 0.5°, 
while the difference between manual and automatic registration was 
on average 0.5mm and 0.4° in each direction (3 observers, 10 
patients). 
(2) Interobserver variation in the delineation of the GTV was on 
average 1 mm and the average GTV center of mass variation was 0.2 
mm (3 observers, 12 patients, 16 lesions).  
(3) An average 97.5% gamma test pass rate for a (2%, 2mm)-criterion 
was found for the 38 included pre-treatment dose verification 
measurements.  
(4) Differences in translations and rotations with respect to the 
average CBCT-CT registration matrix were on average 0.7 mm and 
0.5° in each direction (12 patients, 34 fractions).  
(5) The mean intrafraction vector length was 0.8 mm (39patients, 81 
fractions). 
(6) The average displacement vector found with the end-to-end test 
was 0.9 mm and the average gamma test pass rate for a (2%,2mm)-
criterion was 98% for both linacs used for SBT delivery (4 
measurements). 
Conclusions: The uncertainties found for the analyzed steps are in the 
order of 1 to 2 mm and 1 to 2% dose difference. The 3 mm GTV-PTV 
margin used in clinical practice is adequate given the measured 
uncertainties. A (2%, 2mm)-gamma index criterion with a tolerance of 
95% can be used to evaluate pre-treatment dose verification 
measurements. This methodology can be applied to different 
treatment sites as well to establish the overall treatment accuracy 
and the adequateness of the treatment margins. 
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Purpose/Objective: To describe the method available in our 
department in order to assess the accuracy of the dynamic MLC during 
the delivery of intensity modulated radiosurgery (IMRS) treatments for 
cranial lesions. 
Materials and Methods: Cranial radiosurgery treatments can be 
planned in our department by using intensity modulated technique 
with multiple fixed fields. Plans are calculated with Eclipse TPS (v 
10.0) and delivered with a Varian Clinac 2100 CD equipped with aMLC 
Millennium 120. Eclipse generates a dynamic MLC pattern for each 
field to be run by the linac. It is really interesting to know the 
dynamic MLC behaviour during the delivery in order to determinate 
the impact of the MLC inaccuracies on the planned dose. Dynalog files 
(created by the MLC controller during delivery) give a chance to know 
this impact, as Dynalog files contain detailed information about the 
leaf position and fractional dose delivered by the linac.Hence, it is 
possible to reconstruct the 'actual' fluence pattern for each field; an 
in-house MatLAB code was developed by T.T. for that task. Accuracy 
of this code was previously checked by using the planned leaf 
positions instead the actual ones of the Dynalogs files during the MLC 
reconstruction process. Dose comparison was performed between the 
original plan and the resulting plan including the reconstructed MLCs. 
Five typical IMRTplans were used. After each Dynalog-based fluence 
reconstruction, the corresponding dynamic MLC was imported into 
Eclipse, replacing the original one and a dose re-calculation of the 
reference plan was performed (actual plan). Reference and actual 
plan can be compared by using DHV metric for the PTV and the OARs 
(brainstem, optic nerves and optic chiasma) , in order to assess the 
accuracy of the dynamic MLC in terms of its impact on the patient 
dose distribution. Fifteen cases were analysed in this work. 
Results: Accuracy of the code developed for generation of dynamic 
MLC files from Dynalog files was within ± 0.2 %. The accuracy of the 
fluence delivered by the MLC/linac had an impact of less than 1% on 
the patient dose distribution respect to the reference plan. 
Conclusions: The Dynalog-based method used in this work is a useful 
tool to assess the dynamic of the MLC in terms of impact on the 
patient dose distribution. This method revealed an intra-session high 
accuracy of the MLC used in IMRS single-dose treatments.  
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Purpose/Objective: There has been much discussion recently over the 
optimum way to perform patient specific IMRT QA. It has been 
proposed that it is possible to project IMRT QA measurements made 
normal to the beam using an EPID or array back into the patient 
dataset. This work examines whether applying a correction to this 
projection process for systematic uncertainties associated with the 
linac performance makes a significant difference to the dose 
distribution in the patient. 
Materials and Methods: The QA measurements from 85 consectutively 
generated clinical IMRT plans were re-examined. Each plan had had 
